OPTEL is proud to announce our participation in the HDA 2025 Traceability Seminar, the leading event for pharmaceutical distribution supply chain professionals. This essential gathering brings together manufacturers, wholesalers, distributors, and technology partners to address the complexities of DSCSA compliance and beyond.

Why You Should Meet With OPTEL

As a global leader in intelligent supply chain traceability, OPTEL will showcase our comprehensive pharmaceutical solutions designed to ensure compliance, enhance operational visibility, and most importantly—protect patients and brands.

At the forefront of our presence this year is Verify Brand, OPTEL’s cloud-based platform for serialization and compliance reporting, built to secure brand integrity and maintain trust in the pharmaceutical market.

Explore Verify Brand: Protecting Products, Ensuring Trust

As pharmaceutical serialization enters its final DSCSA phase, brands face new risks from counterfeiting, product diversion, and data silos. Verify Brand, part of OPTEL’s suite of traceability solutions, provides a centralized, secure environment to handle:

• Serialization data management
• Interoperable EPCIS data exchange
• Partner connectivity and alert tracking
• Compliance with U.S. and global regulations

Unlike generic compliance tools, Verify Brand goes beyond the basics—it empowers pharmaceutical companies with full traceability insights across their entire supply chain. This means faster issue resolution, streamlined audits, and more proactive product protection.

Learn how you can:

• Safeguard your product’s reputation
• Improve distributor coordination
• Reduce risk with real-time visibility
• Achieve compliance with confidence